IL-33 regulates adipogenesis via Wnt/β-catenin/PPAR-γ signaling pathway in preadipocytes

Danning Xu,Siqi Zhuang,Hongzhi Chen,Mengjie Jiang,Ping Jiang,Qian Wang,Xuemei Wang,Ruohong Chen,Haoneng Tang,Lingli Tang

DOI: https://doi.org/10.1186/s12967-024-05180-0

IF: 8.44

2024-04-17

Journal of Translational Medicine

Abstract:Abstract Interleukin-33 (IL-33), an emerging cytokine within the IL-1 family, assumes a pivotal function in the control of obesity. However, the specific mechanism of its regulation of obesity formation remains unclear. In this study, we found that the expression level of IL-33 increased in visceral adipose tissue in mice fed with a high-fat diet (HFD) compared with that in mice fed with a normal diet (ND). In vitro, we also found the expression level of IL-33 was upregulated during the adipogenesis of 3T3-L1 cells. Functional test results showed that knockdown of IL-33 in 3T3-L1 cells differentiation could promote the accumulation of lipid droplets, the content of triglyceride and the expression of adipogenic–related genes (i.e. PPAR-γ, C/EBPα, FABP4, LPL, Adipoq and CD36). In contrast, overexpression of IL-33 inhibits adipogenic differentiation. Meanwhile, the above tests were repeated after over-differentiation of 3T3-L1 cells induced by oleic acid, and the results showed that IL-33 played a more significant role in the regulation of adipogenesis. To explore the mechanism, transcriptome sequencing was performed and results showed that IL-33 regulated the PPAR signaling pathway in 3T3-L1 cells. Further, Western blot and confocal microscopy showed that the inhibition of IL-33 could promote PPAR-γ expression by inhibiting the Wnt/β-catenin signal in 3T3-L1 cells. This study demonstrated that IL-33 was an important regulator of preadipocyte differentiation and inhibited adipogenesis by regulating the Wnt/β-catenin/PPAR-γ signaling pathway, which provided a new insight for further research on IL-33 as a new intervention target for metabolic disorders.

medicine, research & experimental

What problem does this paper attempt to address?

This paper aims to explore the role and specific mechanisms of interleukin-33 (IL-33) in the formation of obesity. The study found that in a high-fat diet (HFD)-induced mouse model, the expression level of IL-33 in visceral adipose tissue was significantly elevated. Additionally, during the differentiation of 3T3-L1 preadipocytes, the expression of IL-33 also increased.

Through knockdown and overexpression experiments, researchers found that the downregulation of IL-33 could promote adipocyte differentiation, characterized by increased lipid droplet accumulation, elevated triglyceride content, and upregulated expression of adipogenesis-related genes (such as PPAR-γ, C/EBPα, FABP4, etc.). Conversely, the overexpression of IL-33 inhibited adipocyte differentiation.

Further mechanistic studies indicated that IL-33 affects the expression of PPAR-γ by regulating the Wnt/β-catenin signaling pathway, thereby inhibiting adipogenesis. Specifically, the downregulation of IL-33 promoted the expression of PPAR-γ and inhibited the expression of key proteins in the Wnt/β-catenin signaling pathway (such as β-catenin, LRP6, and p-GSK3β). These results suggest that IL-33 may act as an important regulatory factor, playing a key role in preadipocyte differentiation and the occurrence of obesity. This finding provides a new perspective for the intervention of metabolic disorders.